Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
1.
HIV Med ; 11(6): 379-88, 2010 Jul 01.
Artigo em Inglês | MEDLINE | ID: mdl-20059570

RESUMO

OBJECTIVE: People living with HIV infection are at increased risk for developing cardiovascular disease (CVD). Safe and effective interventions for lowering CVD risk in HIV infection are high priorities. We conducted a prospective, randomized, controlled study to evaluate whether a yoga lifestyle intervention improves CVD risk factors, virological or immunological status, or quality of life (QOL) in HIV-infected adults relative to standard of care treatment in a matched control group. METHODS: Sixty HIV-infected adults with mild-moderate CVD risk were assigned to 20 weeks of supervised yoga practice or standard of care treatment. Baseline and week 20 measures were: 2-h oral glucose tolerance test with insulin monitoring, body composition, fasting serum lipid/lipoprotein profile, resting blood pressures, CD4 T-cell count and plasma HIV RNA, and the Medical Outcomes Study Short Form (SF)-36 health-related QOL inventory. RESULTS: Resting systolic and diastolic blood pressures improved more (P=0.04) in the yoga group (-5 +/- 2 and -3 +/- 1 mmHg, respectively) than in the standard of care group (+1 +/- 2 and+2 +/- 2 mmHg, respectively). However, there was no greater reduction in body weight, fat mass or proatherogenic lipids, or improvements in glucose tolerance or overall QOL after yoga. Immune and virological status was not adversely affected. CONCLUSION: Among traditional lifestyle modifications, yoga is a low-cost, simple to administer, nonpharmacological, popular behavioural intervention that can lower blood pressure in pre-hypertensive HIV-infected adults with mild-moderate CVD risk factors.


Assuntos
Doenças Cardiovasculares/prevenção & controle , Infecções por HIV/complicações , Hipertensão/terapia , Yoga , Adolescente , Adulto , Idoso , Antirretrovirais/efeitos adversos , Área Sob a Curva , Glicemia/metabolismo , Pressão Sanguínea/fisiologia , Composição Corporal/fisiologia , Peso Corporal/fisiologia , Contagem de Linfócito CD4 , Doenças Cardiovasculares/etiologia , Jejum/sangue , Feminino , Humanos , Hipertensão/tratamento farmacológico , Insulina/sangue , Resistência à Insulina/fisiologia , Estilo de Vida , Lipídeos/sangue , Masculino , Pessoa de Meia-Idade , Avaliação de Resultados em Cuidados de Saúde , Estudos Prospectivos , Qualidade de Vida , Fatores de Risco , Carga Viral , Circunferência da Cintura , Adulto Jovem
2.
Artigo em Inglês | MEDLINE | ID: mdl-28856070

RESUMO

Excessive maternal inflammation during pregnancy increases the risk for maternal and neonatal metabolic complications. Fortunately, maternal physical activity during pregnancy appears to reduce maternal inflammation. The purpose of this study was to examine the relationship between maternal physical activity intensity and maternal inflammation during late pregnancy. Maternal physical activity levels (sedentary, light, lifestyle, and moderate), fitness levels, and systemic inflammation (plasma C-reactive protein (CRP) concentration) were measured between 32-37 weeks gestation. Relationships were examined by Spearman Rank Coefficient Correlation analyses. Maternal plasma CRP was negatively associated with time spent in light and lifestyle physical activities (Light: r=-0.40, p=0.01; Lifestyle: r=-0.31, p=0.03), but not with time spent in moderate physical activity (r=-0.18, p=0.21). Higher maternal plasma CRP tended to correlate with more time spent sedentary (r=0.27, p=0.06). In addition, increases in light and lifestyle activities may elicit a clinically meaningful change in inflammation. In conclusion, pregnant women should be encouraged to incorporate more low-intensity physical activities into their daily routines in order to decrease systemic inflammation and potentially improve maternal and neonatal pregnancy outcomes.

3.
HIV Med ; 9(2): 96-100, 2008 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-18093131

RESUMO

BACKGROUND: HIV infection and its treatment, specifically protease inhibitor (PI) therapy, have been associated with an increased risk for cardiovascular disease. Heart rate recovery (HRR) following peak exercise is predictive of future cardiovascular events and mortality in the general population. Nothing is known regarding HRR in individuals infected with HIV on highly active antiretroviral therapy (HAART). SUBJECTS AND METHODS: HIV-positive subjects on HAART that included a PI (HIV+PI, n=19), HIV-positive subjects on HAART that did not include a PI (HIV+noPI, n=19) and HIV-seronegative age, gender and body mass index (BMI) matched controls (Cntl, n=15) underwent a graded maximal exercise test on a cycle ergometer to volitional exhaustion. A continuous electrocardiogram was recorded and HRR was monitored every 30 s for 2 min post exercise. RESULTS: HRR at 1.5 and 2 min was significantly delayed in HIV-positive subjects both on and not on PI-based HAART compared with controls (P<0.01). CONCLUSION: HRR is impaired in HIV-positive individuals on HAART, whether or not the HAART includes a PI, compared with age, gender, BMI, and activity level matched HIV-seronegative controls. Abnormal HRR may reflect cardio-autonomic dysfunction and may be an independent risk factor for future cardiac events in HIV-positive individuals that receive HAART.


Assuntos
Terapia Antirretroviral de Alta Atividade/efeitos adversos , Exercício Físico/fisiologia , Infecções por HIV/tratamento farmacológico , HIV-1 , Cardiopatias/induzido quimicamente , Frequência Cardíaca/efeitos dos fármacos , Estudos de Casos e Controles , Eletrocardiografia , Feminino , Infecções por HIV/fisiopatologia , Cardiopatias/diagnóstico , Humanos , Masculino , Pessoa de Meia-Idade
4.
Am J Physiol Endocrinol Metab ; 290(1): E47-E53, 2006 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-16118251

RESUMO

Dyslipidemia is common in patients with HIV infection. In this study, a two-stage euglycemic hyperinsulinemic clamp, with infusion of stable isotopically labeled tracers, was used to evaluate insulin action in skeletal muscle, liver, and adipose tissue in HIV-infected men with dyslipidemia (HIV-DL; plasma triglyceride >250 mg/dl and HDL <45 mg/dl; n=12), HIV-infected men without dyslipidemia (HIV w/o DL; n=12), and healthy men (n=6). Basal rates of glucose production (glucose R(a)), glucose disposal (glucose R(d)), and lipolysis (palmitate R(a)) were similar between groups. The relative suppression of glucose R(a) (63+/- 4, 77+/- 2, and 78+/- 3%, P=0.008) and palmitate R(a) (49+/-4, 63+/-3, and 68+/-3%, P=0.005) during ow-dose insulin infusion (plasma insulin approximately 30 microU/ml), and the relative stimulation of glucose R(d) (214+/-21, 390+/-25, and 393+/-46%, P=0.001) during high-dose insulin infusion (plasma insulin approximately 75 microU/ml) were lower in HIV-DL than in HIV w/o DL and healthy volunteers, respectively. Suppression of basal glucose R(a) correlated with plasma adiponectin (r=0.44, P=0.02) and inversely with plasma IL-6 (r=-0.49, P<0.001). Stimulation of glucose R(d) correlated directly with adiponectin (r=0.48, P<0.01) and inversely with IL-6 (r=-0.49, P=0.02). We conclude that dyslipidemia in HIV-infected men is indicative of multiorgan insulin resistance, and circulating adipokines may be important in the pathogenesis of impaired insulin action.


Assuntos
Tecido Adiposo/metabolismo , Dislipidemias/sangue , Infecções por HIV/sangue , Resistência à Insulina/fisiologia , Fígado/metabolismo , Músculo Esquelético/metabolismo , Adiponectina/sangue , Tecido Adiposo/efeitos dos fármacos , Adulto , Glicemia/efeitos dos fármacos , Glicemia/metabolismo , Composição Corporal/fisiologia , HDL-Colesterol/sangue , Dislipidemias/complicações , Metabolismo Energético/efeitos dos fármacos , Metabolismo Energético/fisiologia , Ácidos Graxos não Esterificados/sangue , Ácidos Graxos não Esterificados/metabolismo , Glucose/metabolismo , Técnica Clamp de Glucose , Infecções por HIV/complicações , Humanos , Insulina/sangue , Insulina/farmacologia , Fígado/efeitos dos fármacos , Masculino , Pessoa de Meia-Idade , Músculo Esquelético/efeitos dos fármacos , Oxirredução/efeitos dos fármacos , Ácido Palmítico/metabolismo , Triglicerídeos/sangue
5.
Arch Phys Med Rehabil ; 81(11): 1479-84, 2000 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-11083351

RESUMO

OBJECTIVE: To determine the degree to which cardiorespiratory insufficiency limits physical performance in adolescents seropositive for human immunodeficiency virus (HIV). DESIGN: Quasiexperimental, case series design. SETTING: Rehabilitation physiology laboratory. PARTICIPANTS: Seventeen adolescents (12 women, 5 men; age, 18 +/- 2 yr; weight, 74.7 +/- 19.3 kg; height, 170 +/- 9 cm) with HIV infection (viral load, 22,043 +/- 55,869 copies/mL; CD4 count, 499 +/- 210/mL) who were free of comorbid conditions limiting treadmill performance. MAIN OUTCOME MEASURES: Spirometric measurements of oxygen uptake and anaerobic threshold obtained from a peak exercise treadmill test using the modified Bruce protocol. RESULTS: Measured peak oxygen consumption (VO2) was 42% +/- 19% lower than expected (p < .025), suggesting a significant functional aerobic impairment (FAI) or peak VO2 less than 73% of expected values. Peak VO2 was only slightly higher (p < .05) than the oxygen uptake requirements for the most intense activities of daily living (ADL). Anaerobic threshold was only slightly higher (p < .05) than minimum ADL intensities. CONCLUSIONS: Cardiorespiratory insufficiency and FAI limited the ability to perform even low levels of physical activity in these adolescents with mild HIV seropositivity. Disability identified by quantification of FAI may affect implementation of the American with Disabilities Act and public health policy.


Assuntos
Tolerância ao Exercício , Soropositividade para HIV/fisiopatologia , Consumo de Oxigênio , Adolescente , Teste de Esforço , Fadiga/etiologia , Feminino , Soropositividade para HIV/diagnóstico , Humanos , Masculino , Espirometria
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA